Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-54 (IGHV3-54) is one of many variable (V) gene segments in the human immunoglobulin heavy chain locus, located on chromosome 14. This gene segment encodes the variable domain of the heavy chain in antibodies produced by B cells. Together with diversity (D) and joining (J) gene segments, it forms the variable region responsible for antigen binding. The heavy chain variable domain is central to the specificity and diversity of antibodies, enabling effective recognition and elimination of a broad array of pathogens. The IGHV3-54 gene segment is part of the germline repertoire that shapes an individual’s immune response capacity and has known genetic polymorphisms that may affect disease susceptibility, antibody responses, and vaccine efficacy[1][5]. Key points: - IGHV3-54 is a *germline immunoglobulin gene segment, not a typical therapeutic target*. - It has essential roles in *adaptive immunity* through the generation of antibody diversity. - Drug interactions and specific safety issues are not applicable, but the gene is a component of processes central to immune function[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-54 (IGHV3-54).